1,298 material Form 8-K filings that 1,057 companies we cover made with the SEC in April 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
AdaptHealth and its subsidiary AdaptHealth LLC entered a credit agreement dated April 10, 2026, with Bank of America as administrative agent, and used it to repay the prior credit agreement from January 20, 2021. The new facility provides $450 million of revolving commitments, $325 million of initial term loans and $325 million of delayed draw term loans, and matures in April 2031. The company says the new terms carry lower pricing, and it does not expect the transaction to affect its full-year 2026 guidance.
Facility includes $450 million in revolving commitments, $325 million in initial term loans and $325 million in delayed draw term loans available for up to two years after closing.
Credit agreement dated April 10, 2026; scheduled maturity April 13, 2031, subject to a springing maturity 91 days before the 2028 Senior Notes mature if more than $15 million remains outstanding.
Proceeds repaid the prior credit agreement with Regions Bank; the company says the lowest pricing tier fell from 1.50% to 1.125% over SOFR.
The company does not expect the transaction to affect full-year 2026 guidance issued February 24, 2026.
Fastenal reported first-quarter 2026 results for the period ended March 31, 2026. Net sales rose 12.4% to $2.2 billion, net income rose 13.8% to $339.8 million, and diluted earnings per share were $0.30, up from $0.26 a year earlier. Shareholders also received $295.7 million in dividends and share repurchases during the quarter.
Net sales were $2,201.7 million, up 12.4% from $1,959.4 million; daily sales rose 12.4%.
Operating income rose 13.6% to $447.6 million, with operating margin at 20.3% versus 20.1%.
Gross margin fell to 44.6% from 45.1%, which the company attributed mainly to unfavorable price/cost.
Operating cash flow was $378.4 million, or 111.4% of net income, and the company returned $295.7 million to shareholders.
Goldman Sachs reported first-quarter 2026 net revenues of $17.23 billion and net earnings of $5.63 billion, with diluted earnings per share of $17.55, up from $14.12 a year earlier. Results were driven mainly by Global Banking & Markets, and the firm also declared a $4.50 per share dividend and returned $6.38 billion to common shareholders in the quarter.
Diluted EPS of $17.55 compared with $14.12 in Q1 2025 and $14.01 in Q4 2025
Net revenues of $17.23 billion, 14% higher than Q1 2025 and 28% higher than Q4 2025
Board declared a $4.50 per share dividend payable June 29, 2026, to holders of record June 1, 2026
Firm repurchased $5.00 billion of common shares (5.4 million shares) and paid $1.38 billion in common dividends in the quarter
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.